FindTrial
Sign In

Quality Indicators of care in Pediatric Medulloblastoma

OBSERVATIONAL STUDY ON ADHERENCE TO QUALITY INDICATORS OF CARE IN PEDIATRIC MEDULLOBLASTOMA (AQIM)

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2022/11/047162
Enrollment
60
Registered
2022-11-09
Start date
Unknown
Completion date
Unknown
Last updated
2022-11-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C716- Malignant neoplasm of cerebellum

Interventions

None listed

Sponsors

Dr Rimpa Basu Achari PI
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Age Histologically proven medulloblastoma Planned for curative treatment/ received curative treatment at TMC Kolkata

Exclusion criteria

Exclusion criteria: Patients treated for recurrent disease Patients receiving palliative treatment

Design outcomes

Primary

MeasureTime frame
Proportion of treatment courses where all pre-defined quality indicators were adhered to. Timepoint: 3 months—

Secondary

MeasureTime frame
1. Determine reasons for non-adherence to quality indicators 2. Evaluate association between baseline patient factors and adherence to quality indicators 3. Evaluate association between adherence to quality indicators with outcomes viz overall and progression free survival determined by the hazard ratioTimepoint: 3 months—

Countries

India

Contacts

Public ContactSebanti Sarkar

Tata Medical Center

rimpaachari@gmail.com9051584999

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026